InfuSystem Holdings (INFU) Capital Expenditures (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Capital Expenditures came in at $157000.0 in Q1 2026, up 121.54% YoY from $70868.7 in Q1 2025, and down 94.11% on a QoQ basis from $2.7 million in Q4 2025.
InfuSystem Holdings (INFU) Capital Expenditures (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 17 years of Capital Expenditures data on file, last reported at $157000.0 in Q1 2026.
- Quarterly Capital Expenditures rose 121.54% year-over-year to $157000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 272.59% YoY) and the FY2025 annual result came in at $3.1 million, up 258.42% from the prior year.
- Capital Expenditures eased to $157000.0 in Q1 2026, from $2.7 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $2.7 million in Q4 2025 to a low of -$2.1 million in Q4 2023.
- A 5-year average of $202882.4 and a median of $157000.0 in 2026 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 904.55% in 2023, down 254.4% in 2023.
- Tracing INFU's Capital Expenditures over 5 years: stood at $1.3 million in 2022, then tumbled by 254.4% to -$2.1 million in 2023, then soared by 60.29% to -$816000.0 in 2024, then soared by 426.84% to $2.7 million in 2025, then slumped by 94.11% to $157000.0 in 2026.
- The last three Capital Expenditures figures came in at $157000.0 (Q1 2026), $2.7 million (Q4 2025), and $79000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 87.50 Mn |
| 10 | InfuSystem Holdings | 244.67 Mn | 243.70 Mn | 21.41 Mn | -74,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -74,000.00 |
| Jun 30, 2026 | -74,000.00 |
| Mar 31, 2026 | 157,000.00 |
| Mar 31, 2026 | 157,000.00 |
| Dec 31, 2025 | 2.67 Mn |
| Dec 31, 2025 | 2.67 Mn |
| Sep 30, 2025 | 79,000.00 |
| Sep 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 1.08 Mn |
| Mar 31, 2025 | -729,000.00 |
| Mar 31, 2025 | -729,000.00 |
| Dec 31, 2024 | -816,000.00 |
| Dec 31, 2024 | -816,000.00 |
| Sep 30, 2024 | -1.66 Mn |
| Sep 30, 2024 | -1.66 Mn |
| Jun 30, 2024 | 895,000.00 |
| Jun 30, 2024 | 895,000.00 |
| Mar 31, 2024 | -376,000.00 |
| Mar 31, 2024 | -376,000.00 |